HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$7.65
Day range
$7.01 - $7.60
Year range
$6.11 - $11.78
Market cap
643.31M USD
Avg Volume
101.01K
P/E ratio
144.60
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 37.20M | 33.45% |
Operating expense | 35.33M | 35.73% |
Net income | -1.72M | -1,640.40% |
Net profit margin | -4.63 | -1,186.11% |
Earnings per share | 0.05 | — |
EBITDA | 815.00K | -29.92% |
Effective tax rate | -1,969.70% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.42M | 96.56% |
Total assets | 166.13M | 32.48% |
Total liabilities | 23.85M | -11.68% |
Total equity | 142.28M | — |
Shares outstanding | 91.31M | — |
Price to book | 6.59 | — |
Return on assets | 0.18% | — |
Return on capital | 0.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.72M | -1,640.40% |
Cash from operations | -5.62M | -103.95% |
Cash from investing | 1.85M | 192.22% |
Cash from financing | 318.00K | -67.01% |
Net change in cash | -3.33M | 17.79% |
Free cash flow | -3.83M | -32.85% |
About
Founded
1997
Headquarters
Website
Employees
625
